In the United Kingdom (UK), the number of pregnancies in HIV-infected women has increased dramatically over the last decade, but attitudes towards childbearing among infected women have not been previously described. The aim of this survey was to explore fertility intentions among HIV-infected women and to assess the effect of HIV treatment and interventions for prevention of mother-to-child transmission (PMTCT) on these intentions. HIV-infected women, aged between 16 and 49 years, attending one of seven HIV clinics in the UK between July 2003 and January 2004 were asked to complete a questionnaire. Information on demographic factors, HIV test history, pregnancy history and fertility intentions (i.e., desire for children) was collected. Eighty-six per cent of eligible women (450/521) completed the questionnaire. Three quarters of women (336/450) reported that they wanted (more) children. Forty-five per cent (201/450) reported that HIV diagnosis did not affect their fertility intentions, 11% (50/450) that it made them want children sooner, and 10% (44/450) did not know or reported other views. About one third of women (155/450) decided they no longer wanted children after their HIV diagnosis, but 41% of these (59/144) had changed their mind following advances in HIV management and treatment. Factors associated with an increase in fertility intentions after advances in HIV management and treatment were being in a partnership and having fewer than two children. In this survey of HIV-infected women, the majority wanted children and women were more likely to want children after improvements in HIV management and treatment. These findings highlight the need for specialised family planning and reproductive health services targeting this population.
Introduction
In the United Kingdom (UK), the number of new HIV diagnoses in women has increased substantially over the last decade, as has HIV prevalence among women giving birth, which rose from 0.06% in 1997 to 0.21% in 2008 (Health Protection Agency, 2009a . Following the successful implementation of routine antenatal HIV screening throughout the UK from 1999 onwards (Townsend, Cliffe, & Tookey, 2006) , reports of pregnancies in diagnosed HIV-infected women increased from around 130 in 1997 to almost 1400 in 2006 (Townsend, Cortina-Borja, Peckham, & Tookey, 2008) . Studies prior to the advent of highly active antiretroviral therapy (HAART) showed reductions in live birth rates and increases in termination rates after HIV diagnosis (De Vincenzi et al., 1997; Stephenson & Griffioen, 1996; van Benthem et al., 2000) , but included little information on the women themselves. Likewise, in African settings where women have limited access to antiretroviral therapy, HIV diagnosis is associated with lower fertility intentions in HIV-positive than HIV-negative women (Kaida et al., 2010; Taulo et al., 2009; Yeatman, 2009 ).
Since 1996, availability of HAART and improvements in HIV management have led to significant reductions in AIDS-related disease and mortality and in the risk of mother-to-child transmission (European Collaborative Study, 2001 , 2005b Mocroft et al., 2003) . Some studies subsequently showed an increase in pregnancy incidence among HIV-infected women (Blair, Hanson, Jones, & Dworkin, 2004; European Collaborative Study, 2005a ) and a corresponding decline in terminations (Massad et al., 2004; Townsend et al., 2008) . Recent studies in resource-rich settings suggest that around a quarter to a third of HIV-infected women of reproductive age intend to have children in the future, with rates approaching those in the general population (Heard, Sitta, & Lert, 2007; Myer, Morroni, & Rebe, 2007; Ogilvie et al., 2007; Stanwood, Cohn, Heiser, & Pugliese, 2007) . Furthermore some studies in Africa have shown an association between the use of HAART and increased fertility intentions (Cooper et al., 2009; Maier et al., 2009) .
In the UK, the impact of improvements in HIV management on reproductive decision-making in HIV-infected women has not been quantified. The aim of this study was, therefore, to explore fertility intentions in HIV-infected women and to assess the effect of HIV diagnosis and advances in treatment and PMTCT interventions on these intentions.
Methods
All HIV-infected women between the ages of 16 and 49 years who were attending one of seven HIV clinics on designated study days between July 2003 and January 2004 were invited to participate in the study. The seven participating National Health Service clinics (three in London and one each in Nottingham, Leicester, Manchester and Edinburgh) were chosen according to their HIV case load in order to include the larger centres and a balance of patient risk factors (Black African ethnicity and use of injecting drugs). All women received an information sheet about the study prior to questionnaire completion. Those who agreed to participate in the survey were asked to sign an informed consent form and complete a questionnaire while waiting for their appointments. Questionnaires could be taken home for completion and were also available in French to facilitate responses from women born in French-speaking countries in Africa. Participants received a retail voucher on completion of the questionnaire. The study was approved by the London Multi-regional Research Ethics Committee and local research ethics committees of institutions involved in the study.
The structured questionnaire was piloted before the study commenced and focused on demographic factors, HIV test history, pregnancy history and fertility intentions, and additional information was collected on factors that may have influenced pregnancy decision-making, including partner's feelings, migratory status and financial situation. No identifying information was requested. For women who declined to participate, basic demographic details (age, area of residence, ethnicity, parity and reason for declining) were requested to inform assessment of potential bias.
Two main outcomes were measured: (1) the impact of HIV diagnosis on fertility intentions and (2) the effect on these intentions of improvements in HIV treatment and PMTCT interventions. The relevant questions were ''Would you like any (more) children?'', ''Having had your HIV diagnosed did you change your mind about wanting (more) children?'', and ''Have treatments and interventions made you change your mind about wanting (more) children?'' Women classified as having fertility intentions were those who had responded yes to the question ''Would you like any (more) children?''
The statistical power of the survey, based on recruitment of 400 women, was assessed prior to implementation, and power calculations were explored focusing on the key outcomes of the study. Data were analysed in Stata versions 8.2 and 11.0 (StataCorp LP, College Station, Texas, US). Univariable analysis was performed to determine factors associated with intention for children. In addition to ethnicity, which was included a priori in all models, factors found to be associated (p B 0.1) with wanting children after HIV diagnosis and/or among women who did not want children after diagnosis, with a change in attitude towards childbearing after improvements in HIV treatment and interventions, were included in multivariable logistic regression models.
Results
A total of 521 women were invited to participate in the survey and 450 (86%) completed the questionnaire, representing about 40% of all women receiving HIV-related care at the participating centres over a one-year period (1160 women were seen in 2002). Limited data were available on 28 (39%) of the 71 women who were invited to participate in the survey but did not complete a questionnaire. These women were similar to those who responded to the questionnaire in terms of age and parity and the most common reason for not completing a questionnaire was lack of interest (data not shown). Of the remaining 44 women, 26 had taken the full questionnaire home for completion but failed to return it and 18 had no interest in the project.
Population characteristics
Women in the survey were predominantly Black African (72%; Table 1 ). Of those born outside the UK (79%), median duration of residence in the UK was 4.5 years (interquartile range [IQR] 2Á11 years). Few women had a history of injecting drug use (8%). Median age was 35 years (IQR 31Á39 years) and median time since diagnosis was three years (IQR 1Á8 years). Thirty-six per cent of women (160/450) described themselves as married or co-habiting; 16% (73/450) had non-cohabiting partners; 27% (123/450) were single; and 21% (94/450) were widowed, separated, or divorced. Of 233 women in a partnership, 46% had an HIV-infected partner, 38% had an uninfected partner and 16% did not know, often because the partner had not been tested (Table 1) . Most women were taking antiretroviral therapy (68%), predominantly triple therapy (53%, 162/304).
The majority of the survey population had been pregnant (84%) and 25 women (6%) were pregnant at the time of the survey. About 30% of all women had been diagnosed with HIV during pregnancy (Table 1) .
The median number of children was 1.5 (IQR 0Á2) and median age at first child was 22 years (IQR 20Á27 years). Three quarters of women (336/450) stated that they would like (more) children, of whom over one fifth (73/336) reported that they had experienced a period of six months or longer when they had tried unsuccessfully for a pregnancy (Table 1) . Of these, 63% (46/73) had sought medical help for fertility.
Compared with other women, Black African women were more likely to live in London (72%, 233/324 vs. 40%, 51/126, p B0.001), less likely to have a partner (49%, 158/324 vs. 60%, 75/126, p 00.041), more likely to have three or more children 
Effect of HIV diagnosis on fertility intentions
In 45% (201/450) of cases, HIV diagnosis had reportedly not affected fertility decision-making (Table 2) ; of these, 36% (72/201) had already had all the children they wanted at the time of diagnosis, 6% (12/201) had never wanted children, and 58% (117/ 201) intended to carry out their childbearing plans regardless of being infected with HIV. Of the 72 women who stated that they had all the children they wanted at the time of diagnosis, 85% (61/72) had two or more children. Eleven per cent of women (50/450) reported that their HIV diagnosis had made them want to have children earlier than they would have otherwise, a third (155/450) no longer wanted to have children, and 10% either did not know or reported other views (Table 2 ). There were no statistically significant differences in the effect of HIV diagnosis on fertility intentions by ethnicity (p 00.08), although Black African women were slightly more likely to report no change in fertility intentions (Table 2) . In univariable analysis of factors associated with not wanting children after diagnosis (excluding 44 women who did not know or gave other responses), age at diagnosis, years since diagnosis and number of children were significantly associated with no longer wanting children (Table 3 ). Factors other than those shown in Table 3 that were not associated with no longer wanting children after HIV diagnosis included region of birth (UK or other), years in the UK, history of injecting drugs, CD4 count and current HIV therapy. In multivariable analysis including ethnicity, age at diagnosis, area of residence, years since diagnosis, number of children, current HIV symptoms and partnership status, the only factors significantly associated with not wanting children after HIV diagnosis were the number of previous children and time since diagnosis ( Table 3) .
Effect of improvements in treatment and PMTCT interventions on fertility intentions
The majority of women were aware of the availability of HIV treatment (95%, 423/447) and PMTCT interventions (91%, 402/443). The impact of improvements in treatment and interventions was explored for women who stated that an HIV diagnosis made them not want children any more and provided information on the effect of treatment and interventions on their fertility intentions (n 0144). Of these, 41% (59/144) changed their mind after improvements in treatment and interventions (Table 2) . In univariable analyses, women with fewer than two children and those in a partnership were significantly more likely to change their mind following improvements in treatment and management (Table 4) . Women with severe HIV symptoms were significantly less likely to change their mind than asymptomatic women (Table 4 ). In addition, although not statistically significant, a lower proportion of non-London residents, Black African women, women over 29 years old and those diagnosed for less than five years changed their mind about not wanting children (Table 4 ). In multivariable analysis of women who initially did not want children after HIV diagnosis, women in a partnership were significantly more likely to have changed their mind than women without a partner, and those with two or more children at the time of the survey were less likely to have changed their mind about wanting children than those with fewer than two children (Table 4 ).
Discussion
In this survey of HIV-infected women, over half reported that their HIV diagnosis either did not affect their fertility intentions (45%) or in some cases made them want children sooner (11%). While a third of women decided they no longer wanted children after HIV diagnosis, nearly half of them changed their mind once they had become aware of advances in HIV management and treatment. Decreased fertility intentions associated with HIV diagnosis have also been reported in other studies in the pre-HAART era (Bedimo, Bessinger, & Kissinger, 1998; De Vincenzi et al., 1997; Stephenson & Griffioen, 1996; van Benthem et al., 2000) and more recently in Africa, where access to HAART remains limited (Taulo et al., 2009; Yeatman, 2009) . Qualitative studies have shown that childbearing intentions in HIV-infected women are affected by personal health-related concerns, fear of transmitting HIV to the child, and societal influences and stigma (Craft, Delaney, Bautista, & Serovich, 2007) . The observed change in childbearing intentions associated with improvements in HIV treatment and PMTCT interventions concurs with reports of higher pregnancy rates and lower termination rates among HIV-infected women since the advent of HAART (Blair et al., 2004; European Collaborative Study, 2005a; Massad et al., 2004; Townsend et al., 2008) . Although we did not specifically ask women why their attitudes had changed, likely reasons include increased survival and slower disease progression (Blair et al., 2004) as well as changing perceptions around the risk of motherto-child transmission. Includes 406 women where clear information on desire for children was reported (excludes 44 women from Table 2 for whom desire for children after HIV diagnosis was classified as Not known or Other). Note: AOR, adjusted odds ratio; CI, confidence interval; OR, odds ratio.
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We found that among women who initially did not want children after HIV diagnosis, being in a partnership and having fewer than two children were associated with a change in intention for children following advances in treatment and interventions. Few studies in resource-rich countries have explored the association between partnership status and fertility intentions among HIV-infected individuals. In a Canadian study, Ogilvie et al. found that women with regular partners were more likely to intend to have children in the future (Ogilvie et al., 2007) , but in two cohort studies in Europe and the United States, partnership status was not a predictor of repeat pregnancy (Bryant et al., 2007; European Collaborative Study, 2005a) . Our findings are consistent with two studies in South Africa, which found that having fewer children and being in a relationship were associated with increased fertility intention (Cooper et al., 2009; Myer et al., 2007) . Other economic and social factors may also influence an HIV-infected woman's pregnancy decisions following diagnosis.
Many of the women in this study had recently arrived in the UK and almost half were not in a partnership. Therefore, while these women may want children, they may have to delay childbearing. Indeed, although fertility intentions have been shown to increase as a result of access to HAART, this does not necessarily translate into an increase in live births rates (Maier et al., 2009) .
Approximately one third of the women in this study were diagnosed with HIV when they sought antenatal care. The introduction of universal antenatal screening has meant that more women are now diagnosed for the first time in pregnancy. In the UK and Ireland, the proportion of HIV-infected pregnant women who were newly diagnosed in pregnancy increased from one third before 2000, when routine antenatal screening was introduced in England, to 60% between 2001 60% between and 2003 60% between (Townsend et al., 2008 .
In this survey, nearly a quarter of women who expressed an intention for children stated that they had previously tried to conceive for more than six (Frodsham, Boag, Barton, & Gilling-Smith, 2006) . The UK guidelines recommend pre-conceptual counselling for HIV-infected women wishing to become pregnant in order to minimise the risk of transmission, both to their infants and to HIVnegative partners (Fakoya et al., 2007) . For women who are on antiretroviral therapy before they conceive, changes to drug regimens may be required to avoid foetal exposure in early pregnancy (Coll, Lopez, & Hernandez, 2008) . In this survey, over one third of women reported having an HIV-negative partner and about half of these reported a desire for children, highlighting the importance of ensuring safe conception among serodiscordant couples. Fertility evaluation is recommended for women who have not conceived after 6Á12 months, with assisted reproduction techniques available in specialist centres (Fakoya et al., 2007) . There is therefore a clear need for integrated sexual and reproductive health services, to ensure that women have access to HIV care and treatment, as well as to appropriate advice on contraception and methods for safe conception and assisted reproduction if required (Fakoya et al., 2007) . Qualitative research into the factors driving fertility intentions among HIV-infected women of different ethnic groups, as well as their partners, would further inform health service requirements. Although a high response rate was achieved in this survey, women who opted out may have differed in some way from those who participated. Since lack of interest was the main reason for non-participation, it is possible that women who opted out were less interested in fertility issues and, therefore, less likely to desire children. Furthermore, as the clinics were selected to include women with a specific risk profile, they were not necessarily representative of the wider population of HIV-infected women in the UK. The majority of women in this survey were Black African (72%) and 53% of women were taking triple antiretroviral therapy, consistent with UK and Ireland national surveillance data (Health Protection Agency, 2009b; Townsend et al., 2008) . In contrast, women surveyed were slightly older (median age 35 years, IQR 31Á39 years) than HIV-infected pregnant women as a whole in the UK and Ireland in 2004Á2006 (median age 30 years, IQR 26Á34 years; Townsend et al., 2008) . As this survey relates to reported fertility intentions and not necessarily to the likelihood of future pregnancies, this age difference was not considered important. In this survey, which did not address current contraception, it was not possible to explore the role of unplanned pregnancy, which is known to be an important issue in this population. For example, in one study of HIV-infected women in Italy, only half had planned their pregnancies (Fiore et al., 2008) . Although this survey was conducted in 2003Á2004, use of effective antiretroviral therapy and programmes for prevention of mother-to-child transmission were already well established in the UK at that time, and results from this survey are therefore still relevant.
In conclusion, the majority of the HIV-infected women interviewed in this study wanted to have children, and about half of the women who initially did not want children after HIV diagnosis changed their mind following improvements in HIV management. These findings highlight the need for integrated health services linking HIV care and treatment with sexual and reproductive health services.
